The Gross Margin of Alphamab Oncology (9966.HK) is 90.58%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 90.58% |
| 2023-12-31 | 74.75% |
| 2022-12-31 | 73.50% |
| 2021-12-31 | 97.93% |
| 2020-12-31 | 97.93% |